FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: alcon

Sort
E.g., 2013-05-26
E.g., 2013-05-26
Enter a comma separated list of user names.

Power 3 Medical Products Inc. (PWRM.OB) is a leader in bio-medical research and the commercialization of neurodegenerative disease and cancer biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets.

GreenHouse Holdings, Inc. (OTCQB:GRHU) previously announced the signing of multiple contract awards for its Life Protection (LPI) Governmental Services Division, totaling $6 million. The recently acquired LPI subsidiary provides innovative training, support, design and construction of facilities and services to meet the needs of the U. S. Government, military, and law enforcement agencies.

Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, reported that Power3 delivered four poster presentations at the 2010 International Conference on Alzheimer's Disease (ICAD) in Honolulu, Hawaii.

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Novartis Spending $39 Billion for Alcon

Posted by moneyman on April 7th, 2008

Switzerland's Novartis said Monday it will spend about $39 billion in a two-step bid for a majority stake in U.S. eye-care company Alcon.

The deal for Alcon Inc., which makes Opti-Free contact lens solution and has 14,500 employees worldwide, would be one of the largest in Swiss history.

ADVERTISE WITH US